You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 281 No. 2, January 13, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Continuing Medical Education: JAMA Reader's Choice
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA

January 13, 1999

JAMA. 1999;281:203-204.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Physicians in the United States, Canada, and Mexico

Physicians with current and valid licenses in the United States, Canada, or Mexico who read any 3 of the selected continuing medical education (CME) articles in this issue of JAMA, complete the CME Evaluation Form, and fax it to the number or mail it to the address at the bottom of the CME Evaluation Form are eligible for category 1 CME credit. There is no charge.

The American Medical Association (AMA) is accredited by the Accreditation Council for Continuing Medical Education to sponsor CME for physicians. The AMA designates this educational activity for up to 1 hour of category 1 CME credit per JAMA issue toward the AMA Physician's Recognition Award (PRA). Each physician should claim for credit only those hours that were actually spent in this educational activity.


Physicians in Other Countries
Physicians with current and valid licenses in the United States, Mexico, or Canada are eligible for . . . [Full Text of this Article]


RELATED ARTICLES

Advances in the Treatment of Hypertension
Thomas G. Pickering
JAMA. 1999;281(2):114-116.
EXTRACT | FULL TEXT  

Efficacy and Safety of Lovastatin in Adolescent Males With Heterozygous Familial Hypercholesterolemia: A Randomized Controlled Trial
Evan A. Stein, D. Roger Illingworth, Peter O. Kwiterovich, Jr, Chris A. Liacouras, Martti A. Siimes, Marc S. Jacobson, Thomas G. Brewster, Paul Hopkins, Michael Davidson, Kevin Graham, Frederick Arensman, Robert H. Knopp, Carlos DuJovne, Christine L. Williams, Jonathan L. Isaacsohn, Carol A. Jacobsen, Peter M. Laskarzewski, Sharon Ames, and Glenn J. Gormley
JAMA. 1999;281(2):137-144.
ABSTRACT | FULL TEXT  

A Structured Teaching and Self-management Program for Patients Receiving Oral Anticoagulation: A Randomized Controlled Trial
Peter T. Sawicki and for the Working Group for the Study of Patient Self-Management of Oral Anticoagulation
JAMA. 1999;281(2):145-150.
ABSTRACT | FULL TEXT  

Lack of Long-term Effects of In Utero Exposure to Zidovudine Among Uninfected Children Born to HIV-Infected Women
Mary Culnane, MaryGlenn Fowler, Sophia S. Lee, George McSherry, Michael Brady, Karen O'Donnell, Lynne Mofenson, Steven L. Gortmaker, David E. Shapiro, Gwendolyn Scott, Eleanor Jimenez, Ellen C. Moore, Clemente Diaz, Patricia M. Flynn, Bethann Cunningham, James Oleske, and for the Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams
JAMA. 1999;281(2):151-157.
ABSTRACT | FULL TEXT  

Multinational Outbreak of Salmonella enterica Serotype Newport Infections Due to Contaminated Alfalfa Sprouts
Chris A. Van Beneden, William E. Keene, Robert A. Strang, Denise H. Werker, Arlene S. King, Barbara Mahon, Katrina Hedberg, Alison Bell, Michael T. Kelly, Vijay K. Balan, William R. Mac Kenzie, and David Fleming
JAMA. 1999;281(2):158-162.
ABSTRACT | FULL TEXT  

Quality End-of-Life Care: Patients' Perspectives
Peter A. Singer, Douglas K. Martin, and Merrijoy Kelner
JAMA. 1999;281(2):163-168.
ABSTRACT | FULL TEXT  

Comparable Specificity of 2 Commercial Tuberculin Reagents in Persons at Low Risk for Tuberculous Infection
Margarita E. Villarino, William Burman, Yong-Chen Wang, Linda Lundergan, Antonino Catanzaro, Naomi Bock, Crystal Jones, and Charles Nolan
JAMA. 1999;281(2):169-171.
ABSTRACT | FULL TEXT  

Management of Ventricular Arrhythmias: Detection, Drugs, and Devices
David S. Cannom and Eric N. Prystowsky
JAMA. 1999;281(2):172-179.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.